Targeted mechanism of action claims in direct to consumer prescription drug promotion

Ended Awarded Last action

Contract number
75F40119F19019
Awardee
Awarding agency
Obligated
$526,321

Award facts

Opportunity
  • TFTPMC000874B Solicitation number
Contract value 100% obligated
$526,321.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Other Administrative Action P00004 $0
Other Administrative Action P00003 · Modification no: P00003 to invoice processing platform (IPP). Targeted mechanism of action claims in direct to consumer prescription drug promotion. $0
Supplemental Agreement for work within scope P00002 $0
Change Order P00001 $0
Original award $526,321

About this award

This is a Firm Fixed Price contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Research Triangle Institute (RTI) International, a non-profit research organization. The $526,321.00 contract was awarded on July 16, 2019 under the FDA's Mission Oriented Business Integrated Services (MOBIS) federal contract vehicle, and the work is scheduled for completion on February 3, 2024.

The contract is for "Targeted Mechanism of Action Claims in Direct to Consumer Prescription Drug Promotion", which involves social science research services for the FDA. RTI has leveraged its expertise in public health, economics, and data analytics to support federal initiatives and inform programs and policies. For this contract, RTI has subcontracted with L&E Research, Inc., a for-profit focus group and qualitative research firm, to assist with specific research tasks like patient recruiting and data collection. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 75F40119F19019?

75F40119F19019 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on July 16, 2019.

How much is contract 75F40119F19019 worth?

The government has obligated $526,321 on 75F40119F19019.

Is contract 75F40119F19019 an order under another contract?

Yes. 75F40119F19019 is a BPA call under GS10F0097L-HHSF223201510002B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).

Was contract 75F40119F19019 competed?

The extent of competition for 75F40119F19019 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award